![](/img/cover-not-exists.png)
P276âComparative effects of ixekizumab (IXE) vs adalimumab (ADA) across PsA patients defined by baseline characteristics: week 24 outcomes from SPIRIT-H2H
Tahir, Hasan, Bradley, Andrew J, Nassab, Mani H, Möller, Burkhard, Smolen, Josef S, Sapin, Christophe, Dionello, Carla F, Meszaros, GabriellaVolume:
59
Journal:
Rheumatology
DOI:
10.1093/rheumatology/keaa111.269
Date:
April, 2020
File:
PDF, 71 KB
2020